BSE filing, NSE: SANPA. Summary written from the filing by ALFA Finder's alert engine.
Sangal Papers Ltd: key numbers
- Share price
- ₹189.70
- Market cap
- ₹24.80 Cr
- Revenue (annual)
- ₹179.3 Cr
- Net profit (annual)
- ₹2.37 Cr
- P/E (TTM)
- 5.8×Sector 45.0×
- Promoter holding
- 39.48%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sangal Papers Ltd
All →Sangal Papers Management Change
Sangal Papers intimated the demise of Cost Auditor CMA S.R. Kapur on October 18, 2026. The company will fill the casual vacancy within statutory timelines.
Sangal Papers Other Announcement
Sangal Papers Ltd filed an update regarding the administrative rectification of typographical errors in its Registered Office address on the MCA portal.
Sangal Papers Board Meeting Outcome
Sangal Papers Limited's board approved correcting clerical and typographical errors in its registered office address records. No physical shifting or relocation of the office has occurred.
Sangal Papers Legal & Regulatory
Sangal Papers Limited received a rectification order from the Income Tax Department for A.Y. 2025-2026. The order raises a tax demand of ₹0.15 Crore.
- Value
- ₹0.15 Cr
- From
- Income Tax Department
Sangal Papers Management Change
Sanjal Papers re-appointed Tanmay Sangal and Vinayak Sangal as Non-Executive Non-Independent Directors for 12 months effective September 2026. No financial impact accompanies this routine board compliance filing.
- Execution
- 12 months
Sangal Papers Annual General Meeting
Sangal Papers filed 46th AGM proceedings held 23 Sep 2026 via VC/OAVM. Routine items included FY26 financials adoption and two director re-appointments by rotation.
Other adverse business impact announcements
All →Capillary Technologies India Adverse Business Impact
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
- Value
- ₹32.24 Cr
Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr
Hindustan Organic Chemicals Adverse Business Impact
Hindustan Organic Chemicals temporarily shuts down its Kochi Hydrogen plant from 29 October 2026 for pipeline repair and urgent maintenance. Reopening date to be communicated separately.
IIFL Capital Services Adverse Business Impact
IIFL Capital Services' subsidiary surrendered its SEBI Investment Adviser registration, effective October 28, 2026. The company states there is no material monetary impact and no penalty.
Ecoboard Industries Adverse Business Impact
Ecoboard suspended its Particle Board division for one year over raw material shortages and non-viability. Venkatraman Krishnamurthi was appointed CEO, while Gottumukkala steps down to MD.
- Execution
- One (1) year temporary suspension